炎症性腸疾患の新規感受性遺伝子を明らかにする組織横断的トランスクリプトームワイド関連研究
Yang Zhou1, Jintao Guo1,2
1Department of Gastroenterology, Shengjing Hospital of China Medical University, Shenyang, Liaoning Province, China.
Abstract:
Inflammatory bowel disease (IBD), including ulcerative colitis (UC) and Crohn's disease (CD), is an autoimmune disease with a strong genetic component. Although genome-wide association studies (GWAS) have identified multiple risk loci, the underlying causal genes and biological mechanisms remain predominantly elusive. GWAS data for IBD, UC, and CD were obtained from the FinnGen R10 dataset and integrated with expression quantitative trait locus (eQTL) data from the Genotype-Tissue Expression Project (GTEx) v8 to perform cross-tissue transcriptome-wide association studies (TWAS). Single-tissue TWAS validation was conducted using Functional Summary-based Imputation (FUSION). Multi-marker Analysis of GenoMic Annotation (MAGMA), Mendelian randomization (MR), colocalization, and summary data-based MR (SMR) analyses were applied to identify candidate susceptibility genes. GeneMANIA analysis was performed to explore functional implications. The same analytical framework was used on independent GWAS datasets to assess consistency. 6 susceptibility genes were identified for IBD, 1 for UC, and 2 for CD. These findings were supported by cross- and single-tissue TWAS, MAGMA, MR, colocalization, and SMR analyses. In independent datasets, partial gene-level concordance and substantial consistent pathway-level signals were observed. GeneMANIA analyses suggested that susceptibility genes in IBD, UC, and CD were mainly associated with 3',5'-cyclic-nucleotide phosphodiesterase activity, transition metal ion transmembrane transporter activity, and CENP-A-containing chromatin organization, respectively. By integrating cross-tissue TWAS with multi-tier validation strategies, this study provides new insights into the genetic architecture of IBD. Further functional studies are necessary to elucidate the mechanisms by which these candidate genes contribute to IBD pathogenesis.
さらに関連する動画
関連する概念動画
Inflammatory Bowel Disease II: Crohn's Disease
Inflammatory bowel disease, commonly known as IBD, refers to a collection of disorders that lead to persistent inflammation of the gastrointestinal tract. The two types of IBD are ulcerative colitis, which impacts the colon, and Crohn's disease, which can involve any part of the gastrointestinal segment.
Crohn's disease
Crohn's disease is a chronic, systemic inflammatory bowel disease (IBD) that predominantly affects the gastrointestinal tract. It is marked by...
Inflammatory Bowel Disease I: Ulcerative Colitis
Inflammatory bowel disease, or IBD, encompasses a group of disorders characterized by chronic inflammation or ulceration of the gastrointestinal tract.
Risk Factors
The exact cause of IBD remains unclear, although it is believed to be due to a mix of genetic, environmental, microbial, and immune factors. Genetic factors are significant in determining susceptibility to IBD, with family history being a critical risk factor. Individuals with a first-degree relative who has IBD are at...
Inflammatory Bowel Disease V: Surgical Management
Here are some common surgical interventions for IBD:
Inflammatory Bowel Disease IV: Pharmacological Management
Pharmacologic...
Inflammatory Bowel Disease III: Diagnostic Studies and Management I-Nutritional Therapy
Diagnostic studies
A colonoscopy is the definitive screening test, distinguishing ulcerative colitis from other colon diseases with similar symptoms. During a colonoscopy test, inflamed mucosa with exudate ulcerations can be observed, and biopsies are taken to determine the histologic characteristics of the...
Genome-wide Association Studies-GWAS
GWAS does not require the identification of the target gene involved in...


